These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26273636)

  • 21. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
    Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
    Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis.
    Robertson LP; Davis MJ
    Rheumatology (Oxford); 2004 Dec; 43(12):1565-8. PubMed ID: 15353608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis.
    Deniz T; Kizilgul M; Uzunlulu M; Oguz A; Isbilen B
    Acta Reumatol Port; 2014; 39(2):137-42. PubMed ID: 24861165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability and validity of the Thai version of bath ankylosing spondylitis indices.
    Kittiyanpanya C; Chaiamnuay S; Asavatanabodee P; Narongroeknawin P
    J Med Assoc Thai; 2014 Apr; 97(4):381-5. PubMed ID: 24964679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity.
    Baspinar S; Kırnap M; Baspınar O; Dizdar OS; Kocer D
    Rheumatol Int; 2016 Nov; 36(11):1609-1616. PubMed ID: 27443556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of disease activity and functional status questionnaires in spondyloarthritis.
    Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
    Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
    DU XN; Li Y; Zhang SL; Zhu J; Huang F
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish.
    Pedersen OB; Hansen GO; Svendsen AJ; Ejstrup L; Junker P
    Scand J Rheumatol; 2007; 36(1):22-7. PubMed ID: 17454931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.
    Kneepkens EL; Krieckaert CL; van der Kleij D; Nurmohamed MT; van der Horst-Bruinsma IE; Rispens T; Wolbink GJ
    Ann Rheum Dis; 2015 Oct; 74(10):1825-9. PubMed ID: 24812290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
    Oktayoglu P; Em S; Tahtasiz M; Bozkurt M; Ucar D; Yazmalar L; Nas K; Yardımeden I; Cevik F; Celik Y; Mete N
    Rheumatol Int; 2013 May; 33(5):1327-31. PubMed ID: 23143556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
    Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].
    Brandt J; Westhoff G; Rudwaleit M; Listing J; Zink A; Braun J; Sieper J
    Z Rheumatol; 2003 Jun; 62(3):264-73. PubMed ID: 12827403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients.
    Wang C; Miao Y; Wu X; Huang Y; Sun M; Zhu Y; Zheng F; Sun W; Dong L
    J Immunol Res; 2016; 2016():6537248. PubMed ID: 27800496
    [No Abstract]   [Full Text] [Related]  

  • 39. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis.
    Claushuis TA; de Vries MK; van der Weijden MA; Visman IM; Nurmohamed MT; Twisk JW; Van der Horst-Bruinsma IE; Crusius JB
    Clin Exp Rheumatol; 2015; 33(2):159-65. PubMed ID: 25603416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
    Yildirim K; Erdal A; Karatay S; Melikoğlu MA; Uğur M; Senel K
    South Med J; 2004 Apr; 97(4):350-3. PubMed ID: 15108827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.